Stay updated on XEN496 in KCNQ2 EPIK Children Clinical Trial
Sign up to get notified when there's something new on the XEN496 in KCNQ2 EPIK Children Clinical Trial page.

Latest updates to the XEN496 in KCNQ2 EPIK Children Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe record for the XEN496 (ezogabine) pediatric KCNQ2-DEE trial is now displayed, including its terminated status, study design, eligibility criteria, locations, outcome measures, and a study protocol document.SummaryDifference61%

- Check17 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check24 days agoChange DetectedA site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check31 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check38 days agoChange DetectedThe ClinicalTrials.gov page remains a 403 Forbidden error page, with its footer revision identifier updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the expected study record, replacing the content with a generic error page. This suggests an access restriction or temporary server issue preventing retrieval of the study details.SummaryDifference19%

Stay in the know with updates to XEN496 in KCNQ2 EPIK Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XEN496 in KCNQ2 EPIK Children Clinical Trial page.